(A)   The testing or processing phase shall consist of a two-step procedure:
      (1)   Initial screening test using an immunoassay testing method; and
      (2)   Confirmation test using gas chromatography/mass spectrometry (GC/MS) method.
   (B)   When the lab receives a urine sample it will conduct an initial screening test to check for the presence of illegal drugs. This initial screening test involves using an immunoassay testing method.
   (C)   The drugs whose use shall be tested for shall include cannabis, cocaine, phencyclidine (PCP), opiates and amphetamines or their metabolites.
   (D)   The threshold levels established by the Department of Health and Human Services for Federal Workplace Drug Testing programs are hereby adopted by reference, and shall automatically include any later amendments and editions of said adopted matter.
   (E)   The laboratory conducting the test must be certified for federal workplace drug testing programs and must adhere to applicable federal rules, regulations and guidelines pertaining to the handling, testing, storage and preservation of samples.
   (F)   Should the initial test produce a positive result for the presence of an illegal drug, the lab will automatically perform a second test. Known as a confirmation test, the second screening involves using a technologically different and more sensitive gas chromatography/mass spectrometry (GC/MS) testing method.
   (G)   The laboratory will report a test result as positive if, and only if, both the initial test and the confirmation test show the presence of an illegal drug.
   (H)   The laboratory will report all test results directly to the Medical Review Officer.
(Prior Code, § 33.25)  (Ord. passed 11-19-1990)